The EPI-PHARE Scientific Interest Group, created at the end of 2018 by ANSM and CNAM, conducts, pilots and coordinates pharmaco-epidemiology studies to enlighten public authorities in their decision-making and meets the growing demand for studies based on the complex and massive data of the French National Health Data System (SNDS).
EPI-PHARE conducts epidemiological studies on health products in real life and publishes its results in international peer-reviewed journals.
For the realisation of its work programme, EPI-PHARE offers to fund a Groupe Leader in pharmaco-epidemiology.
Applications up to May 03rd 2021.
EPI-PHARE conducts pharmaco-epidemiology studies on health products in real life.
Here you will find our latest news.
